Horan Capital Management Has Raised By $2.01 Million Its Gilead Sciences (GILD) Stake; Enstar Group LTD Has 1.07 Sentiment

November 14, 2017 - By Migdalia James

Horan Capital Management increased Gilead Sciences Inc (GILD) stake by 11.45% reported in 2017Q2 SEC filing. Horan Capital Management acquired 28,734 shares as Gilead Sciences Inc (GILD)’s stock declined

8.05%. The Horan Capital Management holds 279,734 shares with $19.80M value, up from 251,000 last quarter. Gilead Sciences Inc now has $93.15 billion valuation. The stock declined 2.09% or $1.53 reaching $71.32 on the news. About 2.70 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since November 14, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Enstar Group Limited is an insurance group that offers capital release solutions and specialty underwriting capabilities through its network of group companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia and other international locations. The company has market cap of $3.58 billion. The Company’s divisions include Non-Life Run-Off, Atrium, StarStone, and Life and Annuities. It has a 21.05 P/E ratio. The Non-life Run-off segment comprises the activities of its subsidiaries that are running off their property and casualty and other non-life lines of business.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences had 106 analyst reports since July 29, 2015 according to SRatingsIntel. Maxim Group maintained it with “Buy” rating and $115 target in Friday, February 12 report. Berenberg initiated the stock with “Buy” rating in Monday, September 12 report. The rating was maintained by RBC Capital Markets on Wednesday, November 2 with “Outperform”. The firm has “Outperform” rating given on Wednesday, September 14 by Credit Suisse. Needham downgraded the stock to “Hold” rating in Tuesday, July 26 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Thursday, July 27 by BMO Capital Markets. The stock has “Buy” rating by Stifel Nicolaus on Monday, November 14. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Friday, April 29 by Citigroup. The stock has “Buy” rating by Vetr on Monday, August 17. The rating was upgraded by Bank of America on Monday, January 18 to “Neutral”.

Since June 1, 2017, it had 0 buys, and 2 insider sales for $5.11 million activity. MARTIN JOHN C had sold 73,333 shares worth $4.78 million on Thursday, June 1. Another trade for 5,000 shares valued at $325,114 was sold by Alton Gregg H.

Investors sentiment increased to 0.93 in Q2 2017. Its up 0.02, from 0.91 in 2017Q1. It increased, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Fayerweather Charles has invested 1.21% in Gilead Sciences, Inc. (NASDAQ:GILD). Jbf Cap reported 1,010 shares stake. Boston reported 9.84M shares stake. Moreover, Aspen Investment Management has 0.15% invested in Gilead Sciences, Inc. (NASDAQ:GILD). 72,510 were accumulated by Guinness Atkinson Asset Mgmt. Carl Domino has 13,819 shares. Moreover, Hourglass Capital Ltd has 2.05% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Blue Capital accumulated 5,963 shares or 0.27% of the stock. Welch Forbes Limited Com has 164,114 shares for 0.32% of their portfolio. Wetherby Asset Mgmt reported 41,256 shares stake. Texas Permanent School Fund stated it has 367,151 shares or 0.34% of all its holdings. Barry Inv Advisors Limited Liability, Massachusetts-based fund reported 7,199 shares. Tb Alternative Assets holds 39,600 shares. The Kentucky-based Kentucky Retirement has invested 0.45% in Gilead Sciences, Inc. (NASDAQ:GILD). Greenwich Wealth Management Ltd Liability Corp holds 9,251 shares or 0.11% of its portfolio.

About 1,468 shares traded. Enstar Group Ltd. (ESGR) has risen 19.80% since November 14, 2016 and is uptrending. It has outperformed by 3.10% the S&P500.


Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: